Thymopentin
Systematic (IUPAC) name | |
---|---|
L-arginyl-L-lysyl-L-α-aspartyl-L-valyl-L-tyrosine | |
Identifiers | |
ATC code | L03AX09 (WHO) |
PubChem | CID 451417 |
ChemSpider | 397640 |
UNII | O3Y80ZF13F |
KEGG | D06117 |
ChEMBL | CHEMBL156025 |
NIAID ChemDB | 000127 |
Synonyms | (3S)-3-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid |
Chemical data | |
Formula | C30H49N9O9 |
Molar mass | 679.76496 g/mol |
| |
| |
(verify) |
Thymopentin is an immunostimulant. As such, it has been used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in several patients for a brief time under specific treatments.[1][2][3]
It is a thymic polypeptide.[5]
References
- ↑ Mascart-Lemone F, Huygen K, Clumeck N, Brenez D, Bolla K, Duchateau J (1983). "Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients". Lancet. 322 (8352): 735–736. doi:10.1016/S0140-6736(83)92271-7. PMID 6193382.
- ↑ Clumeck N, Van de Perre P, Mascart-Lemone F, Cran S, Bolla K, Duchateau J (1984). "Preliminary results on clinical and immunological effects of thymopentin in AIDS". Int J Clin Pharmacol Res 4: 459–463. PMID 6398315.
- ↑ Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K (1985). "Thymopentin treatment in AIDS and pre-AIDS patients". Surv Immunol Res 4 (1): supp1 58–62. PMID 3898293.
- ↑ Liu Z, Zheng X, Wang J, Wang E (2007). Egli, Martin, ed. "Molecular analysis of thymopentin binding to HLA-DR molecules". PLoS ONE 2 (12): e1348. doi:10.1371/journal.pone.0001348. PMC 2137936. PMID 18159232.
- ↑ Peng Y, Chen Z, Yu W, et al. (July 2008). "Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells". Cell biology international 32 (10): 1265–71. doi:10.1016/j.cellbi.2008.07.011. PMID 18692582.
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.